Clinical Adhesion Study Between ZTlido 1.8% and Three Over-the-counter External Analgesic Lidocaine-containing Patches
Status:
Completed
Trial end date:
2021-07-21
Target enrollment:
Participant gender:
Summary
The study is designed to evaluate and compare the clinical adhesion performance of the ZTlido
(Lidocaine Topical System) 1.8% of Scilex Pharmaceuticals Inc. (Reference) versus Salonpas
(Lidocaine Patch 4%), Aspercreme (Lidocaine Patch 4%) and IcyHot (Lidocaine 4% + Menthol 1%
Patch), on the Mid to upper back while being worn for 12 hours in healthy adult human
subjects.